Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bee Pharm is an Egyptian biotechnology company specializing in apitherapy and the development of natural health products derived from honeybee secretions. The company focuses on the extraction and purification of bee venom, propolis, royal jelly, and pollen to create therapeutic ointments, supplements, and skincare solutions. Their flagship products often target inflammatory conditions such as rheumatoid arthritis and joint pain, leveraging the bioactive properties of melittin and other bee-derived compounds. Bee Pharm integrates traditional apiculture with modern pharmaceutical standards to provide natural alternatives for immune support and pain management. The company is recognized for its research-driven approach to standardized bee-derived therapeutics in the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bee Pharm Apiculture.